U.S. Apheresis Equipment Market Size & Outlook, 2023-2030
U.S. apheresis equipment market, 2018-2030 (US$M)
Related Markets
U.S. apheresis equipment market highlights
- The U.S. apheresis equipment market generated a revenue of USD 917.9 million in 2023 and is expected to reach USD 1,636.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 8.6% from 2024 to 2030.
- In terms of segment, disposable apheresis kits was the largest revenue generating product in 2023.
- Devices is the most lucrative product segment registering the fastest growth during the forecast period.
Apheresis equipment market data book summary
| Market revenue in 2023 | USD 917.9 million |
| Market revenue in 2030 | USD 1,636.2 million |
| Growth rate | 8.6% (CAGR from 2023 to 2030) |
| Largest segment | Disposable apheresis kits |
| Fastest growing segment | Devices |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Disposable Apheresis Kits, Devices |
| Key market players worldwide | Asahi Kasei Corp, Terumo Corp, Fresenius SE & Co KGaA, Haemonetics Corp, B. Braun, Nikkiso Co Ltd, Mallinckrodt PLC Ordinary Shares - New |
Other key industry trends
- In terms of revenue, U.S. accounted for 31.7% of the global apheresis equipment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. apheresis equipment market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 1,636.2 million by 2030.
Disposable apheresis kits was the largest segment with a revenue share of 71.97% in 2023. Horizon Databook has segmented the U.S. apheresis equipment market based on disposable apheresis kits, devices covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing healthcare spending, rising government initiatives, the growing prevalence of blood-related & chronic diseases, the increasing demand for plasma-derived medicines, and the growing number of blood donation drives & camps are driving the growth of this market in the U.S. The key players in the country include B. Braun Melsungen AG; Haemonetics Corporation; Fresenius Kabi AG; Asahi Kasei Medical Co., Ltd.; Terumo BCT, Inc.; and Mallinckrodt.
For instance, in September 2023, BioLineRx Ltd. announced FDA approval of APHEXDA (motixafortide) with filgrastim for mobilizing hematopoietic stem cells in multiple myeloma patients. As apheresis equipment used in stem cell collection, separates desired blood components from donors or patients, facilitating procedures like leukapheresis and HPC collection for various medical treatments.
FDA approval of APHEXDA for stem cell mobilization in multiple myeloma patients could drive demand for apheresis equipment in the U.S. In addition, in August 2023, FDA-cleared Terumo's Reveos Automated Whole Blood System automates platelet separation, enhancing efficiency and increasing availability for patients. It simplifies blood processing, potentially addressing platelet supply challenges.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Apheresis Equipment Market Scope
Apheresis Equipment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. apheresis equipment market size, by product, 2018-2030 (US$M)
U.S. Apheresis Equipment Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
